Falcon 9 sends 27 Starlink satellites into orbit
The Falcon 9 rocket launched from Cape Canaveral Space Force Station just before 2:30 a.m.
It's sending 27 Starlink satellites into low Earth orbit.
Following the stage separation, the first stage landed on a drone ship in the Atlantic Ocean.
Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
34 minutes ago
- CBS News
Detecting, monitoring skin cancers made easier with new screening technology
According to the American Cancer Society, more than 100,000 people will be diagnosed with melanoma this year. The good news is now that treatments have advanced, death rates have declined. Diagnostic tools have also vastly improved to detect and monitor skin cancers. Vectra WB180 system takes just seconds to photograph spots Dr. Jonathan Unger, medical director of the Waldman Melanoma and Skin Cancer Center at Mount Sinai, showed CBS News New York the Vectra WB180 system. "Basically, it is a total body photography system," Unger said. "We use 26 cameras to photograph the entire body ... And then the system takes all of these photos, high-resolution photos, and stitches them together into a three-dimensional avatar." The Vectra WB180 system uses 26 cameras to photograph the entire body so doctors can monitor spots on patients' skin. CBS News New York This is relatively new screening technology with about 100 machines across the country. Unger says it takes just a matter of seconds instead of all the time necessary to photograph each individual spot. "Gives us a memory of every spot on the patient's body, right? Once we have a moment in time, we can always look back and say, what did this thing look like? Was it there? Was it not there? Has it been changing?" he said. He adds accessing details of a patient's mole is much quicker, again, taking only seconds. There are additional benefits to this technology, as well. "Decide with greater certainty and more information whether something needs to be checked, tested, biopsied, et cetera," he said. "In our practice, it's really reduced the number of biopsies because a lot of our patients have hundreds, if not more than that, moles, all of which are irregular." He continued, "This allows us to have a higher level of confidence about what we're looking at and making a decision about." "It gives me the ability to take a deep breath and enjoy my life" Patient Jackie Mills has her spots scrutinized with the new machine after a scare several years ago. "In about 2020, I noticed a spot on my face that was new and rapidly changing," she said. But Mills says her dermatologist at that time wasn't that concerned. "I felt like it was getting bigger, changing colors, it was more jagged, and I really had to push and advocate for myself," she said. "Just had a gut feeling that something was wrong, and I was right." Mills was finally diagnosed with melanoma and had Mohs surgery to have the spot removed. "I had to kind of take it in for a minute and be like, I'm going to have a scar on my face for the rest of my life," she said. "It was that or not be here." Now she's checked every six months. "Not only is Dr. Unger looking at my spots, but he's using this machine to mathematically track what's going on from year to year. And I think that's just, it gives me the ability to take a deep breath and enjoy my life and not be constantly worried about melanoma coming back or being an issue," Mills said. The biggest safety tip from doctors is to use sunscreen every day. It can help prevent sunburn, premature aging and skin cancer.
Yahoo
2 hours ago
- Yahoo
Ready-made stem cell therapies for pets could be coming
Earlier this week, San Diego startup Gallant announced $18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to veterinary medicine. If it passes regulatory muster, it could create a whole new way to treat our fur babies. It's still an experimental field, even though people have been researching stem cells for humans for decades. Seven-year-old Gallant's first target is a painful mouth condition in cats called Feline Chronic Gingivostomatitis (FCGS), which Gallant says could receive FDA approval by early 2026. The field has shown some encouraging early results. Studies on dogs with arthritis showed improvements in pain and mobility, with some benefits lasting up to two years. But when researchers tried similar treatments for kidney disease in cats — that's another condition Gallant wants to tackle — the results were more mixed. What makes Gallant's approach different is convenience. Most stem cell treatments today require harvesting cells from the patient or donors with matching tissue, whereas Gallant's therapy uses ready-to-use cells from donor animals, even if they are a different species. Investors clearly see potential here. The funding round was led by existing backer Digitalis Ventures, with participation from NovaQuest Capital Management, which previously invested in the first FDA-approved human stem cell therapy. The company has an interesting backstory. Gallant's founder, Aaron Hirschhorn, previously sold DogVacay to its biggest rival in the dog-sitting marketplace, Rover. Hirschhorn passed away in 2021; Gallant is now led by Linda Black, who joined as its president and chief scientific officer from nearly the beginning. Gallant has now raised at least $44 million altogether from investors. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
3 hours ago
- Yahoo
Massive Review Finds No 'Safe' Level of Processed Meat Consumption
We know that processed meat isn't particularly good for us, having already been linked to dementia, diabetes, and cancer, but how much of it counts as a 'safe' level of consumption? According to new research, there's no such thing. US researchers reviewed over 70 previous studies (involving several million participants in total), analyzing the relationships between ultra-processed food and three health issues: type 2 diabetes, ischemic heart disease, and colorectal cancer. Associations for processed meat, sugar-sweetened beverages, and trans fatty acids were looked into, and it was the processed meat that came out with the worst results – even if the amount eaten is only small. "The monotonic increases in health risk with increased consumption of processed meat suggest that there is not a 'safe' amount of processed meat consumption with respect to diabetes or colorectal cancer risk," the team from the University of Washington in Seattle writes in their published paper. Related: It's important to put the research into context. The associations found are relatively weak, they don't prove direct cause and effect, and the analyzed studies relied on self-reported dietary habits (which may not be completely accurate). However, the study has several strengths too – it uses a Burden of Proof method, which is more conservative when assessing impacts on health. The results tend to be minimum values, which means they likely underestimate the true health risk. What's particularly notable here is that minimal increases in consumption still raised risk levels. "Habitual consumption of even small amounts of processed meat, sugary drinks, and trans fatty acids is linked to increased risk of developing type 2 diabetes, ischemic heart disease and colorectal cancer," University of Washington nutrition biologist Demewoz Haile told CNN. For example, the equivalent of one hot dog a day was associated with at least an 11 percent greater risk of type 2 diabetes, and at least a 7 percent greater risk of colorectal cancer, compared to eating no processed meat at all. For beverages, an extra can of sugar-sweetened pop a day was linked to a 8 greater risk of type 2 diabetes, and a 2 percent greater risk of ischemic heart disease, compared to not drinking anything sugary. For trans fatty acids, a small daily amount was associated with a 3 percent increase in risk of ischemic heart disease, compared with zero consumption. "This information provides critical data for public health specialists and policymakers responsible for dietary guidelines and potential initiatives that aim to reduce the consumption of these processed foods," write the researchers. While the study has limitations, its scale and conservative methodology make it worth taking note of. This is backed up by a commentary in the same journal, which does note the role of ultra-processed foods in improving food accessibility and shelf life, particularly in areas with limited access to fresh food. The message from the research team is that cutting out ultra-processed foods as much as possible is the best option for our health. The research has been published in Nature Medicine. Ozempic-Like Drugs Could Treat Chronic Migraines, Trial Finds Gut Bacteria Found to Soak Up Toxic Forever Chemicals Gene Therapy Can Restore Hearing in Adults, First-of-Its-Kind Trial Shows
